| |
| |
|
| Insider
Information: |
Polymeropoulos Mihael Hristos |
| Relationship: |
|
| City: |
Rockville |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
1,871,730 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$8,647,393 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,871,730 |
|
|
| Total
Value |
$8,647,393 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
17
|
|
Stock
price went up :
|
0
|
7
|
| Stock
price went down : |
0
|
10
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -128.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vanda Pharmaceuticals Inc. |
VNDA |
|
2024-03-05 |
1,871,730 |
2006-11-06 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VNDA |
Vanda Pharmaceuticals Inc... |
President and CEOChairman of t |
• • – |
2024-03-05 |
4 |
S |
$4.13 |
$100,273 |
D/D |
(24,288) |
1,871,730 |
0 |
% |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
President and CEOChairman of t |
• • – |
2024-03-04 |
4 |
S |
$4.24 |
$131,066 |
D/D |
(30,884) |
1,896,018 |
0 |
% |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
President and CEOChairman of t |
• • – |
2024-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
450,000 |
1,926,902 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
President and CEOChairman of t |
• • – |
2023-03-03 |
4 |
S |
$6.25 |
$140,876 |
D/D |
(22,538) |
1,476,902 |
0 |
% |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
President and CEOChairman of t |
• • – |
2023-03-02 |
4 |
S |
$6.23 |
$139,718 |
D/D |
(22,426) |
1,499,440 |
0 |
% |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
President and CEOChairman of t |
• • – |
2023-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
115,000 |
1,521,866 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
President and CEOChairman of t |
• • – |
2022-12-06 |
4 |
S |
$10.61 |
$512,082 |
D/D |
(48,250) |
1,406,866 |
0 |
% |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
President and CEOChairman of t |
• • – |
2022-12-06 |
4 |
OE |
$3.12 |
$235,139 |
D/D |
75,365 |
1,455,116 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
President and CEOChairman of t |
• • – |
2022-12-05 |
4 |
S |
$10.62 |
$506,200 |
D/D |
(47,650) |
1,379,751 |
0 |
% |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
President and CEOChairman of t |
• • – |
2022-12-05 |
4 |
OE |
$3.12 |
$232,861 |
D/D |
74,635 |
1,427,401 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
President and CEOChairman of t |
• • – |
2022-03-02 |
4 |
S |
$11.15 |
$329,945 |
D/D |
(29,588) |
1,352,766 |
0 |
% |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
President and CEOChairman of t |
• • – |
2022-03-01 |
4 |
S |
$11.19 |
$84,015 |
D/D |
(7,508) |
1,382,354 |
0 |
% |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
President and CEOChairman of t |
• • – |
2022-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
115,000 |
1,389,862 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
President and CEO |
• • – |
2021-03-08 |
4 |
S |
$18.00 |
$3,150,053 |
D/D |
(175,000) |
1,221,062 |
0 |
% |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
President and CEO |
• • – |
2021-03-02 |
4 |
S |
$18.34 |
$278,902 |
D/D |
(15,206) |
1,396,062 |
0 |
% |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
President and CEO |
• • – |
2021-03-01 |
4 |
S |
$18.45 |
$138,003 |
D/D |
(7,479) |
1,411,268 |
0 |
% |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
President and CEO |
• • – |
2021-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
115,000 |
1,418,747 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
President and CEO |
• • – |
2020-12-15 |
4 |
S |
$13.00 |
$508,844 |
D/D |
(39,150) |
1,303,747 |
0 |
% |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
President and CEO |
• • – |
2020-12-15 |
4 |
OE |
$8.75 |
$408,301 |
D/D |
46,663 |
1,342,897 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
President and CEO |
• • – |
2020-12-14 |
4 |
S |
$13.19 |
$673,306 |
D/D |
(51,049) |
1,296,234 |
0 |
% |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
President and CEO |
• • – |
2020-12-14 |
4 |
OE |
$8.75 |
$538,300 |
D/D |
61,520 |
1,347,283 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
President and CEO |
• • – |
2020-12-11 |
4 |
OE |
$8.75 |
$365,899 |
D/D |
41,817 |
1,320,816 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
President and CEO |
• • – |
2020-12-11 |
4 |
S |
$12.88 |
$451,360 |
D/D |
(35,053) |
1,285,763 |
0 |
% |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
President and CEO |
• • – |
2020-03-03 |
4 |
S |
$10.98 |
$56,544 |
D/D |
(5,152) |
1,278,999 |
0 |
% |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
President and CEO |
• • – |
2020-03-02 |
4 |
S |
$10.57 |
$110,211 |
D/D |
(10,428) |
1,284,151 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
